Abnormalities and dysfunction in B cell regulation have long been recognized as a central feature of systemic lupus erythematosus (SLE). Less understood is what causes the dysfunctions seen in SLE […]
Like the rest of medicine, the pace of clinical research and improvement in rheumatology far outstrips the pace of clinical practice improvement. Medical practitioners at all levels are far quicker […]
Pediatric rheumatology — one of the most vibrant and productive communities in the specialty — has several presentations at the Annual Meeting, but the best of the best are gathered […]
Significant change is coming to the management of juvenile dermatomyositis (JDM) for the first time in decades. Two of the first-ever clinical trials in JDM, new therapeutic agents, and new […]
Advances in technology have produced a growing variety of new educational tools and models. Learners generally like these new approaches, but there are very few studies that examine long-term retention […]
2017 has been a busy year in Washington. “We had the Obamacare debates in stops and starts that seemed to go away, Medicare payment reform, high drug prices, transparency in […]
A Sunday State-of-the-Art Lecture will cover the latest findings related to reactive arthritis, including the biological mechanisms that link microbial factors to arthritis and some of the management implications. Emerging […]
While many rheumatologists recognize that pain is highly dependent on the physical structure of joints and supporting tissues, not everyone has the detailed anatomical knowledge of the ankle and foot, […]
A little fuzzy on innate versus adaptive immunity? Not quite clear on T cells and B cells, neutrophils, and macrophages? Looking for a quick catch up on the latest details […]
It’s time to reshape the relationships between rheumatologists and pharmacy benefit managers (PBMs). Many providers see PBMs playing a larger role in complicating patient treatment than in eliminating bottlenecks that […]